Strategic Advisory
Advising life science companies and investors on IP strategy, company positioning, capital strategy, and transaction readiness at critical inflection points.
Advising life science companies, investors, and boards on IP strategy, company positioning, capital raising, and transaction readiness at critical inflection points
I advise biotech and health innovation companies on how to position themselves for investment, partnerships, and growth. I combine deep IP and scientific understanding with strategic and commercial insight, enabling clients to strengthen their equity story and maximize long-term value. I work closely with founders, boards, and investors at pivotal stages of company development.
I work with companies at the moments that matter most - when the right strategic choices define long-term value.
read more about approachAdvising life science companies and investors on IP strategy, company positioning, capital strategy, and transaction readiness at critical inflection points.
Serving as board member, chair, or strategic advisor to leadership teams, providing experienced guidance on governance, strategy, and value creation.
Advising venture funds on deal sourcing, due diligence, IP evaluation, and portfolio company strategy.
Delivering talks, moderating panels, and contributing to strategic discussions on life science innovation, leadership, and diversity in the sector.
Book a meeting with me and let’s explore how we can work together.
book a callA strong sense of responsibility underpins every engagement. I provide honest, independent advice-even when it is challenging-and take ownership of the quality and impact of the work I deliver.
Decisions in life sciences shape value over many years. The focus is not on short-term optimization, but on building sustainable positions-scientifically, strategically, and financially.
Complex science requires clear strategic choices. Lene supports leadership teams in defining priorities, evaluating trade-offs, and making decisions that stand up to investor, partner, and board scrutiny.
Capital is a critical resource. A disciplined approach ensures that financing strategies, resource allocation, and development plans are aligned to maximize long-term value creation.
Value in life sciences is often realized through partnerships. The approach emphasizes positioning, credibility, and alignment-ensuring companies are prepared to engage with investors, pharma, and other stakeholders from a position of strength.
Alexandra Hoegberg - March 7, 2026
read more
Nordic Life Science
read more
Alexandra Hoegberg - March 7, 2026
read more
Alexandra Hoegberg - March 7, 2026
read moreNordic Life Science
read moreBioStock
read moreBioStock
read moreCoulter Partners
read morePOV International
read moreDansk Industri
read moreBusiness Review
read moreDDW
read moreVestbee
read moreI work with companies, investors, and boards at critical moments where strategic decisions have long-term consequences. My approach is grounded in facts, shaped by experience, and focused on delivering real outcomes.
I engage as a trusted advisor-bringing clarity to complex situations, challenging assumptions, and ensuring that strategic choices are both robust and actionable.
Founder of LG BioCapital, advising life science companies, investors, and boards on IP strategy, company positioning, capital strategy and raising, and transaction readiness.
Advising on IP strategy, company positioning, and investor readiness for a clinical-stage biotechnology company developing next-generation T-cell therapies.
Supporting deal sourcing, IP evaluation, and strategic assessment of life science and planetary health investments.
Board member in 23 life science companies, including 18 roles as chairperson. Extensive experience in governance, strategic oversight, and guiding companies through critical value-creating decisions.
12 years of experience as an investor in venture capital funds, with deep involvement in evaluating life science opportunities, portfolio strategy, and value creation.
European Patent Attorney with extensive experience in IP strategy, patent portfolio development, and the role of IP in transactions, financing, and company positioning.
Senior roles in biotech and pharma business development, strategy, and IP, with a focus on licensing, partnerships, and corporate development.
Co-founder and leader of a Nordic network focused on increasing diversity and unlocking talent in life sciences. Driving strategic initiatives, partnerships, and cross-Nordic collaboration. The network covers Denmark, Norway and Finland.
Co-founder of an initiative working to increase diversity among investors in venture capital and the startup ecosystem. Based in London.
Name
This section will showcase selected client testimonials, presented in a dynamic, rotating slider. Each story highlights the impact of our collaboration, offering insight into how we support clients in making confident, high-stakes decisions and achieving meaningful, long-term results.
Discover My LinkedIn Profile & Follow to stay updated
LinkedIn ProfileLet’s connect, book a meeting and discover how we can work together.
lene.gerlach@gmail.com +45 20 31 74 60If you prefer, feel free to fill out the form.